Form 4 for CLX Clorox
Accepted 2022-03-16 00:00:00 ET · period of report 2022-03-14 · accession 0001225208-22-004781 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-03-16 | 2022-03-14 | CLX | Grier Stacey | EVP - Chief Growth, Str Ofc | A - Grant | $127.62 | +470 | 3,503 | +15% | +$60.0K |
| D | 2022-03-16 | 2022-03-14 | CLX | Grier Stacey | EVP - Chief Growth, Str Ofc | A - Grant | $0.00 | +2,907 | 2,907 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-14 | A | A | 470 | $127.62 | 3,503 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2022-03-14 | A | A | 2,907 | $0.00 | 2,907 | D | $127.62 · 2023-03-14 to 2032-03-14 | 2,907 Common Stock | (F2) Option vests in 4 equal installments - 1/4 on each of the first, second, third and fourth anniversaries of the grant date. |